Envision Pharma Group Wins Gold Events & Exhibitions Award at PM Society Awards in Collaboration With Mundipharma
Envision Pharma Group was awarded for outstanding creativity, impact and innovation at the 33rd annual PM Society Awards held at the Grosvenor House in London on February 1, 2019.
The PM Society Awards recognise creativity, impact and innovation across pharmaceutical and healthcare advertising and communications. Their target categories are judged by online healthcare professional surveys, and others by panels drawn from creative agencies and industry.
In addition to winning the Events & Exhibitions Award Gold, Envision also secured a bronze award in the Innovation category.
Global Innovation Director at Envision Vonig Watson said, “Envision Pharma Group are extremely proud to have won both Gold and Bronze at the PM Society Awards for our work in collaboration with Mundipharma.
“Reaching audiences in innovative and engaging ways to offer those individuals real value via tailored experiences has been a real success story for EPG. Gone are the days of forcing content on audiences with the hope of maximum impact and lasting message retention. We understand that audiences choose when and how they engage with content, and in creating unique experiences, we are able to achieve the desired reach and impact. This helps our clients effectively communicate their messages to the right audiences at the right time.
“These awards reflect Envision Pharma Group’s passion in delivering scientific and medical communications effectively. Being selected for this award by an acclaimed judging panel of our peers is recognition of all the hard work that went into achieving this. A huge thank you to the creative team, and to our partners Mundipharma for having the faith and vision to help us bring this to life.”
Click here to access video highlights of this experience, and see our award-winning creative solutions.
About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a global, innovative technology and scientific communications company serving the pharmaceutical, biotechnology, and medical device industries. Envision is a leading provider of evidence communication services and industry leading technology solutions that have applicability across many areas of Medical Affairs and related functional responsibilities. Envision Pharma Group provides services and technology solutions to more than 80 companies, including 19 of the top 20 pharmaceutical companies.
Envision has 13 offices, five in the UK – Bishop’s Stortford, Horsham, London (Hammersmith), Marlow, and Wilmslow; one in Serbia; five in the US – Philadelphia, PA; Southport, CT; Madison, NJ, Stirling, NJ; and Glastonbury, CT; and two in Asia Pacific – Tokyo and Sydney. The company employs more than 700 team members, including over 250 highly qualified in-house medical writers and over 140 technology solutions team members involved with software development and customer support.
For more information about Envision Pharma Group’s Digital and Creative capabilities, visit us at www.envisionpharmagroup.com or contact:
Tel: +44 (0)1279 656656